<VariationArchive VariationID="18374" VariationName="NM_000747.3(CHRNB1):c.1347_1355del (p.Glu449_Glu451del)" VariationType="Deletion" Accession="VCV000018374" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-11" DateCreated="2017-03-08" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="33413" VariationID="18374">
      <GeneList>
        <Gene Symbol="CHRNB1" FullName="cholinergic receptor nicotinic beta 1 subunit" GeneID="1140" HGNC_ID="HGNC:1961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NW_016107299.1" start="65518" stop="78167" display_start="65518" display_stop="78167" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7445061" stop="7457710" display_start="7445061" display_stop="7457710" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7348405" stop="7360931" display_start="7348405" display_stop="7360931" Strand="+" />
          </Location>
          <OMIM>100710</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000747.3(CHRNB1):c.1347_1355del (p.Glu449_Glu451del)</Name>
      <CanonicalSPDI>NC_000017.11:7455918:AGGAACAGGAGGA:AGGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7455919" stop="7455927" display_start="7455919" display_stop="7455927" variantLength="9" positionVCF="7455918" referenceAlleleVCF="CAGGAACAGG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7359238" stop="7359246" display_start="7359238" display_stop="7359246" variantLength="9" positionVCF="7359237" referenceAlleleVCF="CAGGAACAGG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7359242_7359250del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7359242_7359250del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7455923_7455931del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7455923_7455931del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008026.1" sequenceAccession="NG_008026" sequenceVersion="1" change="g.15837_15845del">
            <Expression>NG_008026.1:g.15837_15845del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000747.3" sequenceAccession="NM_000747" sequenceVersion="3" change="c.1347_1355del" MANESelect="true">
            <Expression>NM_000747.3:c.1347_1355del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000738.2" sequenceAccession="NP_000738" sequenceVersion="2" change="p.Glu449_Glu451del">
            <Expression>NP_000738.2:p.Glu449_Glu451del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="100710.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 100710.0003 based on the assumption that the numbering system reported in the paper by Quiram et al., 1999 (PubMed ) was based on the legacy system that uses the mature peptide and by confirming the deletion of the reported codons.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000747.3(CHRNB1):c.1347_1355del (p.Glu449_Glu451del) AND Congenital myasthenic syndrome 2C" Accession="RCV000020042" Version="36">
        <ClassifiedConditionList TraitSetID="21217">
          <ClassifiedCondition DB="MedGen" ID="C4225373">Congenital myasthenic syndrome 2C</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000747.3(CHRNB1):c.1347_1355del (p.Glu449_Glu451del) AND Congenital myasthenic syndrome 2A" Accession="RCV003588563" Version="1">
        <ClassifiedConditionList TraitSetID="21216">
          <ClassifiedCondition DB="MedGen" ID="C4225374">Congenital myasthenic syndrome 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-03-08" MostRecentSubmission="2024-03-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10562302</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21217" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="33151" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome 2C</ElementValue>
                <XRef ID="MONDO:0014582" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMS2C</ElementValue>
                <XRef Type="MIM" ID="616314" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16083" />
                <XRef ID="16083" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="590" DB="Orphanet" />
              <XRef ID="C4225373" DB="MedGen" />
              <XRef ID="MONDO:0014582" DB="MONDO" />
              <XRef Type="MIM" ID="616314" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21216" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myasthenic syndrome, congenital, 2a, slow-channel</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome 2A</ElementValue>
                <XRef ID="MONDO:0014581" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMS2A</ElementValue>
                <XRef Type="MIM" ID="616313" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9895" />
                <XRef ID="9895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="590" DB="Orphanet" />
              <XRef ID="C4225374" DB="MedGen" />
              <XRef ID="MONDO:0014581" DB="MONDO" />
              <XRef Type="MIM" ID="616313" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="40340" SubmissionDate="2017-03-01" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="100710.0003_MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY (1 family)" title="CHRNB1, 9-BP DEL, NT1276_MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY (1 family)" />
        <ClinVarAccession Accession="SCV000040340" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 sibs with congenital myasthenic syndrome-2C associated with acetylcholine receptor deficiency (CMS2C; 616314), Quiram et al. (1999) identified compound heterozygosity for 2 mutations in the CHRNB1 gene. One mutation was a 9-bp deletion (1276del9) in exon 10, resulting in a deletion of 3 codons (426-428) in the long cytoplasmic loop between the M3 and M4 domains of the protein. The second mutation was a skipping of exon 8 (100710.0004), truncating the beta subunit before its M1 transmembrane domain and abolishing surface expression of pentameric AChR. The cause of the exon 8 deletion was not determined. By coexpressing the 3-codon deleted subunit with combinations of wildtype subunits in HEK293 cells, Quiram et al. (1999) demonstrated that the mutation impairs AChR assembly by disrupting a specific interaction between the beta and delta (100720) subunits. Studies with related deletion and missense mutations indicated that secondary structure in this region of the beta subunit is crucial for interaction with the delta subunit. The findings implied that the mutated residues are positioned at the interface between beta and delta subunits and demonstrated contribution of this local region of the long cytoplasmic loop to AChR assembly.</Attribute>
              <Citation>
                <ID Source="PubMed">10562302</ID>
              </Citation>
              <XRef DB="OMIM" ID="616314" Type="MIM" />
              <XRef DB="OMIM" ID="100720" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNB1" />
          </GeneList>
          <Name>CHRNB1, 9-BP DEL, NT1276</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, NT1276</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="100710.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7968678" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4228336|MedGen:C4225374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004282533" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10562302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10562302</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects CHRNB1 function (PMID: 10562302). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 18374). This variant is also known as beta1276del9. This variant has been observed in individual(s) with autosomal recessive congenital myasthenia (PMID: 10562302). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This variant, c.1347_1355del, results in the deletion of 3 amino acid(s) of the CHRNB1 protein (p.Glu449_Glu451del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7359238_7359246del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="40340" TraitType="Disease" MappingType="Name" MappingValue="MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY (1 family)" MappingRef="Preferred">
        <MedGen CUI="C4225373" Name="Congenital myasthenic syndrome 2C" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7968678" TraitType="Disease" MappingType="XRef" MappingValue="C4225374" MappingRef="MedGen">
        <MedGen CUI="C4225374" Name="Congenital myasthenic syndrome 2A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

